Alto Neuroscience, Inc. Common Stock (ANRO)

Total Costs & Expenses

$29.13M

Quarterly · Period ending: · USD

ANRO logo

ANRO Total Costs & Expenses

Latest reported$29.13M
ANRO Quarterly Total Costs & Expenses ($8.06M → $29.13M)
High-resolution chart · PNG

ANRO total costs & expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Alto Neuroscience, Inc. Common Stock Total Costs & Expenses — Quarterly (USD)
Period endingTotal Costs & Expenses (USD)
29,129,000
27,138,000
-115,673,000
14,951,000
18,682,000
15,676,000
16,997,000
18,886,000
18,341,000
14,386,000
11,765,000
9,718,000
9,125,000
7,201,000
8,060,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.